HLA B44-restricted cytotoxic T lymphocyte responses to the peptides of HCV nucleprotein residues 81-100 in patients with chronic hepatitis C
スポンサーリンク
概要
著者
-
OKAMOTO Hiroaki
Immunology Division and Division of Molecular Virology, Jichi Medical School
-
Imawari Michio
自治医科大学附属大宮医療センター
-
Imawari Michio
昭和大学 医学部第二内科学教室
-
Okamoto Hiroaki
Immunology Division And Division Of Molecular Virology Jichi Medical School
-
OHNISHI SHIN
Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo
-
Ohnishi Shin
Third Department Of Internal Medicine Faculty Of Medicine University Of Tokyo
-
Okamoto Hiroshi
Immunology Division Jichi Medical School
-
KITA Hiroto
Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo
-
MORIYAMA Takashi
Hepatology and Immunology Divisions, Jichi Medical School
-
KANEKO Takashi
Hepatology and Immunology Divisions, Jichi Medical School
-
HIROISHI Kazumasa
Hepatology and Immunology Divisions, Jichi Medical School, Second Department of Internal Medicine, F
-
IMAWARI Michio
Hepatology and Immunology Divisions, Jichi Medical School
-
Kita Hiroto
Third Department Of Internal Medicine Faculty Of Medicine University Of Tokyo
-
HIROISHI Kazumasa
Division of Gastroenterology, Department of Medicine, Showa University School of Medicine
-
Imawari Michio
Division Of Gastroenterology Department Of Medicine Showa University School Of Medicine
-
Imawari M
Division Of Gastroenterology Department Of Medicine Showa University School Of Medicine
-
Hiroishi Kazumasa
Division Of Gastroenterology Department Of Medicine Showa University School Of Medicine
-
Moriyama Takashi
Hepatology And Immunology Divisions Jichi Medical School
-
Kaneko Takashi
Hepatology And Immunology Divisions Jichi Medical School
-
Hiroishi Kazumasa
Department Of Gastroenterology Showa University School Of Medicine
関連論文
- TT virus infection in cases of fulminant hepatic failure-evaluation by clonality based on amino acid sequence of hypervariable regions
- Circulating KL-6 level at baseline is a predictive indicator for the occurrence of interstitial pneumonia during interferon treatment for chronic hepatitis C
- TT virus of certain genotypes may reduce the platelet count in patients who achieve a sustained virologic response to interferon treatment for chronic hepatitis C
- Influence of TT virus infection on the thrombocytopenia of patients with chronic liver disease
- Influence of TT virus on the histopathological features of nonalcoholic fatty liver disease
- Influence of TT virus on the clinical course of alcoholic liver disease
- TT virus : virological and genomic characteristics and disease associations
- Helicobacter pylori and TT virus prevalence in Japanese children
- Magnitude of CD8^+ T-cell responses against hepatitis C virus and severity of hepatitis do not necessarily determine outcomes in acute hepatitis C virus infection
- Dendritic cells stimulated with cytidine-phosphate-guanosine oligodeoxynucleotides and interferon-α-expressing tumor cells effectively reduce outgrowth of established tumors in vivo
- Intrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis
- Protein-losing enteropathy associated with hypocomplementemia and anti-nuclear antibodies
- Clinical evaluation of chronic liver diseases induced by different hepatitis C virus genotype in Japan, focused on the difference between genotypes III/2a and IV/2b
- Strong CD8^+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma
- Tacrolimus in corticosteroid-resistant ulcerative colitis
- Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology^1
- Differential effect of cytotoxic T lymphocyte variant epitopes on generation and cytotoxicity in chronic hepatitis C virus infection
- The prevalence of GB virus C, risk factors and its relationship with other hepatitis viruses in a general population in Jakarta, Indonesia
- Cold activation of complement enhancing with the duration of storage in sera from blood donors with hepatitis C virus RNA
- HLA B44-restricted cytotoxic T lymphocyte responses to the peptides of HCV nucleprotein residues 81-100 in patients with chronic hepatitis C
- Measurement of serum PSP/reg-protein concentration in various diseases with a newly developed enzyme-linked immunosorbent assay
- IgM-class antibodies to TT virus (TTV) in patients with acute TTV infection
- A unique set of mutations in the 'preX' region of hepatitis B virus DNA frequently foun in patients but not in asymptomatic carriers: implication for a novel variant
- Hepatitis C virus genotypes and co-infection with GB virus C in patients with anti-HCV-positive chronic liver disease in Jakarta, Indonesia
- Genotypes of GB virus C and hepatitis C virus in hepatitis patients in India, Iran and Slovenia
- Efficacy of hepatitis B vaccines with and without preS2-region product in Sumo wrestlers in Japan
- Molecular and clinical characteristics of the hepatitis C virus genotype '2c' found in Italians in Italy and France
- Infection with GB virus C in the patients with primary hepatocellular carcinoma in Japan
- Prevalence of Anti-Hepatitis C antibodies in a Rural Community without High Mortality from Liver Disease in Niigata Prefecture
- Persistence of hepatitis B viremia after recovery from acute hepatitis B : correlation between anti-HBc titer and HBV DNA in serum
- Cellular immune response in HCV infection
- Cyclooxygenase-2 gene promoter polymorphisms affect susceptibility to hepatitis C virus infection and disease progression
- Th1 and Th2 imbalance in chronic hepatitis C
- Rebound of hepatitis C virus RNA in serum after withdrawal of interferon in patients with advanced liver disease
- Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update